Schizoaffective Disorders Completed Phase 1 Trials for Risperidone (DB00734)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00645502Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.Treatment
NCT02091388Bioavailability of LY03004 and Risperdal® Consta®Treatment
NCT02186769An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderTreatment
NCT02411526Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaTreatment